Company Filing History:
Years Active: 2006
Title: Yangfen Wu: Innovator in Thrombolytic Agents
Introduction
Yangfen Wu is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombolytic agents. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Yangfen Wu holds a patent for "Carboline-3-carboxylic acid modified related sequences of Ala-Arg-Pro-Ala-Lys, their synthesis and use as thrombolytic agent." This invention relates to the protected intermediates and the deprotected products of P6A. It involves the protected pseudopeptides introducing the protected intermediates of P6A to 3S-(2-Boc)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid and the deprotected pseudopeptides. The patent also covers methods for their preparation and their application as thrombolytic agents.
Career Highlights
Yangfen Wu is currently associated with Guangzhou Baiyunshan Pharmaceutical Co., Ltd. His work at this esteemed company has allowed him to focus on innovative pharmaceutical solutions. With a patent portfolio that includes 1 patent, he continues to contribute to the advancement of medical treatments.
Collaborations
Yangfen Wu has collaborated with notable colleagues such as Shiqi Peng and Ming Zhao. Their combined expertise has fostered a productive environment for innovation and research.
Conclusion
Yangfen Wu's contributions to the field of thrombolytic agents exemplify his commitment to medical innovation. His work not only enhances pharmaceutical development but also has the potential to improve patient outcomes significantly.